Calreticulin is a Critical Cell Survival Factor in Malignant Neoplasms.
Calreticulin (CRT) is a high-capacity Ca2+ protein whose expression is up-regulated during cellular transformation and is associated with disease progression in multiple types of malignancies. At the same time, CRT has been characterized as an important stress-response protein capable of inducing im...
Main Authors: | Arum Han, Chen Li, Tara Zahed, Michael Wong, Ian Smith, Karl Hoedel, Douglas Green, Alexander D Boiko |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-09-01
|
Series: | PLoS Biology |
Online Access: | https://doi.org/10.1371/journal.pbio.3000402 |
Similar Items
-
Mutant Calreticulin in the Myeloproliferative Neoplasms
by: Daniel Prins, et al.
Published: (2020-02-01) -
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
by: Pecquet, C, et al.
Published: (2022) -
CALRETICULIN IN MYELOPROLIFERATIVE NEOPLASMS: THE OTHER SIDE OF THE ALICE MIRROR
by: Lilian Varricchio, et al.
Published: (2014-07-01) -
The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia
by: Jingyi Wang, et al.
Published: (2016-08-01) -
Calreticulin Mutations in Myeloproliferative Neoplasms: Comparison of Three Diagnostic Methods.
by: Ji-Hye Park, et al.
Published: (2015-01-01)